The UK NSC recommendation on Long-Chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency (currently in consultation)

 

This recommendation is currently being reviewed as part of the UK NSC's regular review cycle of all policies.

The review process began in Dec 2017 and is estimated to be completed by Apr 2019.

» Download the expert review for LCHADD (PDF document, 3.85MB)

The UK NSC welcomes comments and feedback on the expert review during the consultation period that lasts from 22/10/2018 until 17/01/2019. Please send comments to Screening Evidence by e-mail using this feedback form.

Please note that all consultation submissions will be published on this page when the review is complete. Full details can be found in the confidentiality and disclosure section at the bottom of this page.

Recommendation Systematic population screening programme not recommended
 

Find general information about population health screening.

More about LCHADD

LCHADD is a rare condition where a baby has problems breaking down certain types of fat to produce energy. People with LCHADD are missing an enzyme that helps them break down certain fats.

Babies with LCHADD become ill when their body cannot produce enough energy and develop symptoms including poor feeding, irritability, sleepiness, vomiting, breathing difficulties, floppiness and Low blood sugar (hypoglycaemia).

Without treatment babies can develop heart problems, go into a coma and it can cause death. Treatment involves changing the diet so it is low in particular types of fat.

Stakeholders

British Association of Perinatal Medicine
British Inherited Metabolic Disease Group
Clinical Genetics Society
Faculty of Public Health
Genetic Alliance UK
Institute of Child Health
Metabolic Support UK
MetBio
Royal College of General Practitioners
Royal College of Midwives
Royal College of Paediatrics and Child Health
Royal College of Physicians
Royal College of Physicians and Surgeons of Glasgow
Royal College of Physicians of Edinburgh
Save Babies Through Screening Foundation UK
UK Newborn Screening Laboratories Network

The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.

Recommendation Review History

The policy for LCHADD screening was first recommended in 2014 following a one year evaluation of screening for this condition and four others that can present in newborns.

Related documents

icon Birth Prevalence of Five Inherited Metabolic Diseases (PDF document, 513KB, 06/05/14)
icon Consultation Responses to the 2014 ENBS Review (PDF document, 1.03MB, 06/05/14)
icon Cover Sheet and Consultation Responses (PDF document, 224KB, 06/05/14)
icon ENBS Health Economics Report (PDF document, 561KB, 06/05/14)
icon Expanded Newborn Blood Spot Report (PDF document, 1.47MB, 14/04/14)
icon Expanded Newborn Blood Spot Report 2013 (PDF document, 1.47MB, 22/10/18)
icon FAQs for the ENBS Review (PDF document, 117KB, 06/05/14)

Confidentiality and disclosure

Information provided in response to this consultation, including personal information, may be subject to publication or release to other parties or to disclosure in accordance with the access to information regimes (these are primarily the Freedom of Information Act 2000, the Data Protection Act 1998, and the Environmental Information Regulations 2004). If you want information, including personal data that you provide to be treated as confidential, please be aware that, under the FOIA, there is a statutory Code of Practice with which public authorities must comply and which deals, amongst other things, with obligations of confidence.

In view of this it would be helpful if you could explain to us why you regard the information you have provided as confidential. If we receive a request for disclosure of the information we will take full account of your explanation, but we cannot give an assurance that confidentiality can be maintained in all circumstances. An automatic confidentiality disclaimer generated by your IT system will not, of itself, be regarded as binding on the UK National Screening Committee.

Any request for information to be treated in confidence will be taken into consideration in the publication of responses to the consultation. The UK National Screening Committee intends to publish all responses following the closure of the consultation period, however we will not publish responses from respondents who request that any of the information in their response, including personal data, should be handled in confidence. The UK National Screening Committee reserves the right not to publish or take into account any representations which are openly offensive or defamatory.

More options

Go to top